Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Dutasteride is more efficient than finasteride, but individual results vary.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

A reliable, cost-effective method was developed for accurately measuring finasteride in medicines.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride and low-dose dutasteride combo improves hair growth and reduces hair loss with no major side effects.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Post-finasteride syndrome's existence is uncertain; more research needed.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Finasteride causes lasting fertility decrease in rats.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Finasteride doesn't change rat testicle weight or sperm production.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.